A healthcare AI company has spotted several unexpected, off-label drug combinations that may do the job against COVID-19. In any case, the company is offering its complete AI toolkit free of charge to drug developers working on COVID treatments. In announcing its work, Germany-based Innoplexus, which specializes in AI-based drug discovery and development, says the promising combos emerged from its processing of hundreds of studies covering thousands of patients. Most of the findings mentioned in the announcement involve the potential of the decades-old, much-discussed malaria fighter Hydroxychloroquine as used with other drugs. For example, the analysis showed that combining Chloroquine...